Spectral AI is trading 5.38% up at $1.67 on September 30, 2026, with no company-specific announcement or clearly reported catalyst identified. - The latest company release announced a presentation at the ACS Clinical Congress, scheduled for September 26–29, but does not establish a reason for the gain. - Healthcare-sector weakness is contrary to the stock’s direction; available evidence does not identify a clear driver.